A new state law caps the price of specific medications and medical supplies for chronic diseases. The law, which could save ...

The FDA initially rejected the marketing application for Alhemo in 2022, asking for additional data on dosing and monitoring.

Abbott Laboratories is rated a Buy due to growth indicators, diversified portfolio, strong profit margin. Read an investment ...

Novo Nordisk’s latest attempt in weight loss, a combination drug called CagriSema, matched the bar set by Lilly’s currently ...

Madrigal hit its coverage goal (greater than 80% of commercial lives) a full quarter ahead of schedule, analysts noted, with the majority of prescriptions being the paid variety versus free or via ...

The FDA has approved a new drug called ensartinib for adults with a type of lung cancer called ALK-positive non-small-cell lung cancer (NSCLC).

The FDA on Wednesday approved the drug under the brand name Ensacove as a first-line treatment for ALK-positive non-small ...

As criticism of pharmacy benefit managers heats up, fear of lawsuits is driving some big employers to drop the “Big Three” ...

But in an increasingly competitive market for weight loss drugs, these are not the only options for people looking to lose ...

Shares in major healthcare companies that own pharmacy benefit manager businesses took a nosedive after comments from ...

It's hard to find a worse-performing sector in retail than pharmacy stores. From 2010 to 2021, nearly 30 percent of drug ...